OTC Healthcare in Belgium to 2013

Introduction

This databook provides key data and information on the OTC healthcare market in Belgium. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

*Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data

*Category level company and brand share as well as distribution share information for 2007 and 2008

*Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in Belgium increased at a compound annual growth rate of 2.3% between 2003 and 2008.

The cough and cold preparations category led the OTC healthcare market in Belgium, accounting for a share of 22.4%.

Leading players in Belgian OTC healthcare market include Johnson & Johnson, Novartis AG and Omega Pharma NV.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Belgium

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Market Overview 31
Value analysis (Euro), 2003?08 31
Value analysis (Euro), 2008?13 33
Value analysis (US dollars), 2003?08 35
Value analysis (US dollars), 2008?13 36
Company and brand share analysis 38
Distribution analysis 45
Chapter 4 Leading Company Profiles 47
Johnson & Johnson 47
Novartis AG 49
Chapter 5 Category Analysis: Analgesics 51
Value analysis (Euro), 2003?08 51
Value analysis (Euro), 2008?13 52
Value analysis (US dollars), 2003?08 54
Value analysis (US dollars), 2008?13 55
Company and brand share analysis 57
Distribution analysis 60
Chapter 6 Category Analysis: Topical OTC Medicines 62
Value analysis (Euro), 2003?08 62
Value analysis (Euro), 2008?13 63
Value analysis (US dollars), 2003?08 65
Value analysis (US dollars), 2008?13 66
Company and brand share analysis 68
Distribution analysis 71
Chapter 7 Category Analysis: Cough and Cold Preparations 73
Value analysis (Euro), 2003?08 73
Value analysis (Euro), 2008?13 74
Value analysis (US dollars), 2003?08 76
Value analysis (US dollars), 2008?13 77
Company and brand share analysis 79
Distribution analysis 82
Chapter 8 Category Analysis: Indigestion Preparations 84
Value analysis (Euro), 2003?08 84
Value analysis (Euro), 2008?13 85
Value analysis (US dollars), 2003?08 87
Value analysis (US dollars), 2008?13 87
Company and brand share analysis 89
Distribution analysis 92
Chapter 9 Category Analysis: Medicated Skin Products 94
Value analysis (Euro), 2003?08 94
Value analysis (Euro), 2008?13 95
Value analysis (US dollars), 2003?08 97
Value analysis (US dollars), 2008?13 98
Company and brand share analysis 100
Distribution analysis 103
Chapter 10 Category Analysis: First Aid Kits 105
Value analysis (Euro), 2003?08 105
Value analysis (Euro), 2008?13 106
Value analysis (US dollars), 2003?08 107
Value analysis (US dollars), 2008?13 107
Company and brand share analysis 108
Distribution analysis 111
Chapter 11 Category Analysis: Other OTC Healthcare Products 113
Value analysis (Euro), 2003?08 113
Value analysis (Euro), 2008?13 114
Value analysis (US dollars), 2003?08 116
Value analysis (US dollars), 2008?13 117
Company and brand share analysis 119
Distribution analysis 124
Chapter 12 Category Analysis: Plasters & Bandages 126
Value analysis (Euro), 2003?08 126
Value analysis (Euro), 2008?13 127
Value analysis (US dollars), 2003?08 129
Value analysis (US dollars), 2008?13 130
Company and brand share analysis 132
Distribution analysis 135
Chapter 13 Category Analysis: Traditional Medicines 137
Value analysis (Euro), 2003?08 137
Value analysis (Euro), 2008?13 138
Value analysis (US dollars), 2003?08 139
Value analysis (US dollars), 2008?13 139
Company and brand share analysis 140
Distribution analysis 143
Chapter 14 Category Analysis: Vitamins and Minerals 145
Value analysis (Euro), 2003?08 145
Value analysis (Euro), 2008?13 146
Value analysis (US dollars), 2003?08 148
Value analysis (US dollars), 2008?13 148
Company and brand share analysis 150
Distribution analysis 153
Chapter 15 Country Comparison 155
Value 155
Market share 159
Chapter 16 PESTLE Analysis 160
Summary 160
Political analysis 161
Economic analysis 165
Social analysis 169
Technological analysis 173
Legal analysis 177
Environmental analysis 180
Chapter 17 New Product Development 183
Product launches over time 183
Recent product launches 185
Chapter 18 Macroeconomic Profile 186
Macroeconomic indicators 186
Chapter 19 Research Methodology 191
Methodology overview 191
Secondary research 192
Market modeling 193
Creating an initial data model 193
Revising the initial data model 193
Creating a final estimate 194
Creating demographic value splits 194
Primary research 194
Data finalization 195
Ongoing research 195
Chapter 20 APPENDIX 196
Future readings 196
How to contact experts in your industry 196
Disclaimer 196

LIST OF FIGURES
Figure 1: Belgium OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 34
Figure 2: Belgium OTC healthcare category growth comparison, by value, 2003?13 37
Figure 3: Belgium OTC healthcare company share, by value, 2007?08 (%) 42
Figure 4: Belgium OTC healthcare distribution channels, by value, 2007?08 (%) 46
Figure 5: Belgium analgesics value and value forecast, 2003?13 (€m, nominal prices) 53
Figure 6: Belgium analgesics category growth comparison, by value, 2003?13 56
Figure 7: Belgium analgesics company share, by value, 2007?08 (%) 58
Figure 8: Belgium analgesics distribution channels, by value, 2007?08 (%) 61
Figure 9: Belgium topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 64
Figure 10: Belgium topical OTC medicines category growth comparison, by value, 2003?13 67
Figure 11: Belgium topical OTC medicines company share, by value, 2007?08 (%) 69
Figure 12: Belgium topical OTC medicines distribution channels, by value, 2007?08 (%) 72
Figure 13: Belgium cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 75
Figure 14: Belgium cough and cold preparations category growth comparison, by value, 2003?13 78
Figure 15: Belgium cough and cold preparations company share, by value, 2007?08 (%) 80
Figure 16: Belgium cough and cold preparations distribution channels, by value, 2007?08 (%) 83
Figure 17: Belgium indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 86
Figure 18: Belgium indigestion preparations category growth comparison, by value, 2003?13 88
Figure 19: Belgium indigestion preparations company share, by value, 2007?08 (%) 90
Figure 20: Belgium indigestion preparations distribution channels, by value, 2007?08 (%) 93
Figure 21: Belgium medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 96
Figure 22: Belgium medicated skin products category growth comparison, by value, 2003?13 99
Figure 23: Belgium medicated skin products company share, by value, 2007?08 (%) 101
Figure 24: Belgium medicated skin products distribution channels, by value, 2007?08 (%) 104
Figure 25: Belgium first aid kits value and value forecast, 2003?13 (€m, nominal prices) 106
Figure 26: Belgium first aid kits company share, by value, 2007?08 (%) 109
Figure 27: Belgium first aid kits distribution channels, by value, 2007?08 (%) 112
Figure 28: Belgium other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 115
Figure 29: Belgium other OTC healthcare products category growth comparison, by value, 2003?13 118
Figure 30: Belgium other OTC healthcare products company share, by value, 2007?08 (%) 121
Figure 31: Belgium other OTC healthcare products distribution channels, by value, 2007?08 (%) 125
Figure 32: Belgium plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 128
Figure 33: Belgium plasters & bandages category growth comparison, by value, 2003?13 131
Figure 34: Belgium plasters & bandages company share, by value, 2007?08 (%) 133
Figure 35: Belgium plasters & bandages distribution channels, by value, 2007?08 (%) 136
Figure 36: Belgium traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 138
Figure 37: Belgium traditional medicines company share, by value, 2007?08 (%) 141
Figure 38: Belgium traditional medicines distribution channels, by value, 2007?08 (%) 144
Figure 39: Belgium vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 147
Figure 40: Belgium vitamins and minerals category growth comparison, by value, 2003?13 149
Figure 41: Belgium vitamins and minerals company share, by value, 2007?08 (%) 151
Figure 42: Belgium vitamins and minerals distribution channels, by value, 2007?08 (%) 154
Figure 43: Global OTC healthcare market split (value terms, 2008), top five countries 156
Figure 44: Global OTC healthcare market value, 2003–08, top five countries 158
Figure 45: Annual data review process 192

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: Belgium OTC healthcare value, 2003?08 (€m, nominal prices) 32
Table 4: Belgium OTC healthcare value forecast, 2008?13 (€m, nominal prices) 33
Table 5: Belgium OTC healthcare value, 2003?08 ($m, nominal prices) 35
Table 6: Belgium OTC healthcare value forecast, 2008?13 ($m, nominal prices) 36
Table 7: Belgium OTC healthcare brand share, by value, 2007?08 (%) 38
Table 8: Belgium OTC healthcare value, by brand 2007?08 (€m, nominal prices) 40
Table 9: Belgium OTC healthcare company share by value, 2007?08 (%) 43
Table 10: Belgium OTC healthcare value, by company, 2007?08 (€m, nominal prices) 44
Table 11: Belgium OTC healthcare distribution channels, by value, 2007?08 (%) 45
Table 12: Belgium OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 45
Table 13: Johnson & Johnson key facts 47
Table 14: Novartis AG key facts 49
Table 15: Belgium analgesics value, 2003?08 (€m, nominal prices) 51
Table 16: Belgium analgesics value forecast, 2008?13 (€m, nominal prices) 52
Table 17: Belgium analgesics value, 2003?08 ($m, nominal prices) 54
Table 18: Belgium analgesics value forecast, 2008?13 ($m, nominal prices) 55
Table 19: Belgium analgesics brand share, by value, 2007?08 (%) 57
Table 20: Belgium analgesics value, by brand 2007?08 (€m, nominal prices) 57
Table 21: Belgium analgesics company share by value, 2007?08 (%) 59
Table 22: Belgium analgesics value, by company, 2007?08 (€m, nominal prices) 59
Table 23: Belgium analgesics distribution channels, by value, 2007?08 (%) 60
Table 24: Belgium analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 60
Table 25: Belgium topical OTC medicines value, 2003?08 (€m, nominal prices) 62
Table 26: Belgium topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 63
Table 27: Belgium topical OTC medicines value, 2003?08 ($m, nominal prices) 65
Table 28: Belgium topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 66
Table 29: Belgium topical OTC medicines brand share, by value, 2007?08 (%) 68
Table 30: Belgium topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 68
Table 31: Belgium topical OTC medicines company share by value, 2007?08 (%) 70
Table 32: Belgium topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 70
Table 33: Belgium topical OTC medicines distribution channels, by value, 2007?08 (%) 71
Table 34: Belgium topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 71
Table 35: Belgium cough and cold preparations value, 2003?08 (€m, nominal prices) 73
Table 36: Belgium cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 74
Table 37: Belgium cough and cold preparations value, 2003?08 ($m, nominal prices) 76
Table 38: Belgium cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 77
Table 39: Belgium cough and cold preparations brand share, by value, 2007?08 (%) 79
Table 40: Belgium cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 79
Table 41: Belgium cough and cold preparations company share by value, 2007?08 (%) 81
Table 42: Belgium cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 81
Table 43: Belgium cough and cold preparations distribution channels, by value, 2007?08 (%) 82
Table 44: Belgium cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 82
Table 45: Belgium indigestion preparations value, 2003?08 (€m, nominal prices) 84
Table 46: Belgium indigestion preparations value forecast, 2008?13 (€m, nominal prices) 85
Table 47: Belgium indigestion preparations value, 2003?08 ($m, nominal prices) 87
Table 48: Belgium indigestion preparations value forecast, 2008?13 ($m, nominal prices) 87
Table 49: Belgium indigestion preparations brand share, by value, 2007?08 (%) 89
Table 50: Belgium indigestion preparations value, by brand 2007?08 (€m, nominal prices) 89
Table 51: Belgium indigestion preparations company share by value, 2007?08 (%) 91
Table 52: Belgium indigestion preparations value, by company, 2007?08 (€m, nominal prices) 91
Table 53: Belgium indigestion preparations distribution channels, by value, 2007?08 (%) 92
Table 54: Belgium indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 92
Table 55: Belgium medicated skin products value, 2003?08 (€m, nominal prices) 94
Table 56: Belgium medicated skin products value forecast, 2008?13 (€m, nominal prices) 95
Table 57: Belgium medicated skin products value, 2003?08 ($m, nominal prices) 97
Table 58: Belgium medicated skin products value forecast, 2008?13 ($m, nominal prices) 98
Table 59: Belgium medicated skin products brand share, by value, 2007?08 (%) 100
Table 60: Belgium medicated skin products value, by brand 2007?08 (€m, nominal prices) 100
Table 61: Belgium medicated skin products company share by value, 2007?08 (%) 102
Table 62: Belgium medicated skin products value, by company, 2007?08 (€m, nominal prices) 102
Table 63: Belgium medicated skin products distribution channels, by value, 2007?08 (%) 103
Table 64: Belgium medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 103
Table 65: Belgium first aid kits value, 2003?08 (€m, nominal prices) 105
Table 66: Belgium first aid kits value forecast, 2008?13 (€m, nominal prices) 106
Table 67: Belgium first aid kits value, 2003?08 ($m, nominal prices) 107
Table 68: Belgium first aid kits value forecast, 2008?13 ($m, nominal prices) 107
Table 69: Belgium first aid kits brand share, by value, 2007?08 (%) 108
Table 70: Belgium first aid kits value, by brand 2007?08 (€m, nominal prices) 108
Table 71: Belgium first aid kits company share by value, 2007?08 (%) 110
Table 72: Belgium first aid kits value, by company, 2007?08 (€m, nominal prices) 110
Table 73: Belgium first aid kits distribution channels, by value, 2007?08 (%) 111
Table 74: Belgium first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 111
Table 75: Belgium other OTC healthcare products value, 2003?08 (€m, nominal prices) 113
Table 76: Belgium other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 114
Table 77: Belgium other OTC healthcare products value, 2003?08 ($m, nominal prices) 116
Table 78: Belgium other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 117
Table 79: Belgium other OTC healthcare products brand share, by value, 2007?08 (%) 119
Table 80: Belgium other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 120
Table 81: Belgium other OTC healthcare products company share by value, 2007?08 (%) 122
Table 82: Belgium other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 123
Table 83: Belgium other OTC healthcare products distribution channels, by value, 2007?08 (%) 124
Table 84: Belgium other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 124
Table 85: Belgium plasters & bandages value, 2003?08 (€m, nominal prices) 126
Table 86: Belgium plasters & bandages value forecast, 2008?13 (€m, nominal prices) 127
Table 87: Belgium plasters & bandages value, 2003?08 ($m, nominal prices) 129
Table 88: Belgium plasters & bandages value forecast, 2008?13 ($m, nominal prices) 130
Table 89: Belgium plasters & bandages brand share, by value, 2007?08 (%) 132
Table 90: Belgium plasters & bandages value, by brand 2007?08 (€m, nominal prices) 132
Table 91: Belgium plasters & bandages company share by value, 2007?08 (%) 134
Table 92: Belgium plasters & bandages value, by company, 2007?08 (€m, nominal prices) 134
Table 93: Belgium plasters & bandages distribution channels, by value, 2007?08 (%) 135
Table 94: Belgium plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 135
Table 95: Belgium traditional medicines value, 2003?08 (€m, nominal prices) 137
Table 96: Belgium traditional medicines value forecast, 2008?13 (€m, nominal prices) 138
Table 97: Belgium traditional medicines value, 2003?08 ($m, nominal prices) 139
Table 98: Belgium traditional medicines value forecast, 2008?13 ($m, nominal prices) 139
Table 99: Belgium traditional medicines brand share, by value, 2007?08 (%) 140
Table 100: Belgium traditional medicines value, by brand 2007?08 (€m, nominal prices) 140
Table 101: Belgium traditional medicines company share by value, 2007?08 (%) 142
Table 102: Belgium traditional medicines value, by company, 2007?08 (€m, nominal prices) 142
Table 103: Belgium traditional medicines distribution channels, by value, 2007?08 (%) 143
Table 104: Belgium traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 143
Table 105: Belgium vitamins and minerals value, 2003?08 (€m, nominal prices) 145
Table 106: Belgium vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 146
Table 107: Belgium vitamins and minerals value, 2003?08 ($m, nominal prices) 148
Table 108: Belgium vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 148
Table 109: Belgium vitamins and minerals brand share, by value, 2007?08 (%) 150
Table 110: Belgium vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 150
Table 111: Belgium vitamins and minerals company share by value, 2007?08 (%) 152
Table 112: Belgium vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 152
Table 113: Belgium vitamins and minerals distribution channels, by value, 2007?08 (%) 153
Table 114: Belgium vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 153
Table 115: Global OTC healthcare market value, 2008 155
Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 158
Table 117: Leading players, top five countries 159
Table 118: Analysis of Belgium’s political landscape 161
Table 119: Analysis of Belgium’s economy 165
Table 120: Analysis of Belgium’s social system 169
Table 121: Analysis of Belgium’s technology landscape 173
Table 122: Patents granted by the US Patent and Trademark Office to major EU countries, 2000–06 176
Table 123: Analysis of Belgium’s legal landscape 177
Table 124: Analysis of Belgium’s environmental landscape 180
Table 125: Belgium OTC healthcare new product launches reports, by company (top five companies), 2008 183
Table 126: Belgium OTC healthcare new product launches SKUs, by company (top five companies), 2008 183
Table 127: Belgium OTC healthcare new product launches (reports), by flavor and fragrances, 2008 184
Table 128: Belgium OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 184
Table 129: Belgium OTC healthcare new product launches (reports), by package tags or claims, 2008 185
Table 130: Belgium OTC healthcare new product launches - recent five launches 2008 185
Table 131: Belgium population, by age group, 2003?08 (millions) 186
Table 132: Belgium population forecast, by age group, 2008?13 (millions) 187
Table 133: Belgium population, by gender, 2003?08 (millions) 187
Table 134: Belgium population forecast, by gender, 2008?13 (millions) 188
Table 135: Belgium nominal GDP, 2003?08 (€bn, nominal prices) 188
Table 136: Belgium nominal GDP forecast, 2008?13 (€bn, nominal prices) 188
Table 137: Belgium real GDP, 2003?08 (€bn, 2000 prices) 189
Table 138: Belgium real GDP forecast, 2008?13 (€bn, 2000 prices) 189
Table 139: Belgium real GDP, 2003?08 ($bn, 2000 prices) 189
Table 140: Belgium real GDP forecast, 2008?13 ($bn, 2000 prices) 190
Table 141: Belgium consumer price index, 2003?08 (2000=100) 190
Table 142: Belgium consumer price index, 2008?13 (2000=100) 190



[Inhaltsverzeichnis ausblenden]